- 60.3k views
Pediatric Muscular Dystrophy
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.
About the Speaker
Dr. Rama Krishna Cheruvu
Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad
Dr. Rama Krishna Cheruvuis currently working as Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad. He is a highly experienced pediatrician with over 20 years of clinical experience. Graduating as the best outgoing student and recipient of the Dr. Lavanya Mukherjee Prize from Andhra Medical College, Visakhapatnam, in 2001, Dr. [Name] also holds a postgraduate degree in Clinical Research and Regulatory Affairs from Sikkim Manipal University. As a life member of the Indian Academy of Pediatrics (IAP), Dr. [Name] actively participates in community health programs and serves as a speaker and delegate in local IAP events. Currently, Dr. [Name] is a Senior Consultant Pediatrician at Mayflower Hospital and Trinity Hospital in Hyderabad, with special interests in infectious diseases, immunization, child growth, nutrition, and adolescent counseling.
Upcoming Case Discussions
Scale Healthcare Brands with AI-Powered Marketing
The AI revolution in medicine is transforming healthcare, making it smarter and more efficient than ever before. From early disease detection to personalized treatment plans, AI empowers doctors with data-driven insights for better decision-making. Robotic surgeries and AI-assisted diagnostics are enhancing precision and reducing human error. AI also improves patient care through virtual assistants and remote monitoring tools. This technological leap is paving the way for a future where healthcare is more accessible, accurate, and innovative.
Comprehensive Approaches to Pediatric Practice
Comprehensive approaches to pediatric practice emphasize holistic care that integrates early screening, preventive measures, and tailored treatments. These strategies involve using tools like the NISA card for early detection of conditions such as iron deficiency anemia. Regular anthropometric assessments provide insight into growth and development, allowing for early intervention. Incorporating neurodevelopmental screening tools ensures that cognitive, emotional, and physical milestones are monitored effectively. Collaborative care models, including parental involvement and education, support continuous patient engagement. Digital health tools can enhance monitoring and streamline consultations. Multidisciplinary teams can address complex cases more efficiently. Preventive care and health education are prioritized to reduce long-term risks. Comprehensive approaches foster a proactive environment that adapts to each child's needs. The result is improved health outcomes and overall child well-being.
Case Based Discussion on Bronchiolitis
Bronchiolitis is a common respiratory infection in infants and young children, primarily caused by the respiratory syncytial virus (RSV). It presents with nasal congestion, cough, wheezing, and difficulty breathing, often following an upper respiratory infection. Management is largely supportive, focusing on hydration, oxygen therapy, and suctioning nasal secretions. Routine use of bronchodilators, steroids, or antibiotics is not recommended. Severe cases may require hospitalization for respiratory support, such as high-flow nasal cannula or mechanical ventilation. Preventive measures include proper hand hygiene and, in high-risk infants, palivizumab prophylaxis. Prompt recognition and appropriate care are key to reducing complications and improving outcomes.
Diabetic Complications in 12 Questions
Diabetic complications in 12 Questions" is designed to address common concerns related to the long-term effects of diabetes, such as neuropathy, retinopathy, and cardiovascular issues. Through a Q&A format, the session aims to educate participants on prevention, early detection, and management strategies for these complications to improve overall diabetic care.
Management of ICU Delirium
The management of ICU delirium involves a combination of preventive strategies, such as early mobilization, minimizing sedation, and addressing underlying medical causes, to reduce the risk and severity of delirium in critically ill patients. Treatment includes optimizing the patient's environment, using non-pharmacological interventions, and, if necessary, medications to manage symptoms while focusing on long-term cognitive recovery.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Rama Krishna Cheruvu's Talks on Assimilate
- 26th-June-2024, TIME : 5:00PM TO 6:00 PM
- 0
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.